AptarGroup (ATR) reported quarterly earnings results on Thursday, Jul-28-2016. The company said it had a profit of $0.91 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.01. Analysts had a consensus of $0.90. The company posted revenue of $620.00 million in the period, compared to analysts expectations of $620.24 million. The company’s revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.82 EPS.
AptarGroup closed down -0.34 points or -0.43% at $79.38 with 2,39,102 shares getting traded on Thursday. Post opening the session at $79.71, the shares hit an intraday low of $78.97 and an intraday high of $79.99 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
In a different news, on Jun 2, 2016, Stephen J Hagge (President and CEO) sold 25,000 shares at $76.84 per share price. According to the SEC, on Mar 21, 2016, Robert Kuhn (EVP & CFO) sold 5,000 shares at $76.43 per share price. On Mar 21, 2016, Peter Pfeiffer (director) sold 143,000 shares at $76.97 per share price, according to the Form-4 filing with the securities and exchange commission.
AptarGroup Inc. is a solution provider of a range of packaging delivery solutions for the beauty personal care home care prescription drug consumer health care injectables food and beverage markets. The Company has manufacturing facilities located throughout the world including North America Europe Asia and South America. It offers various dispensing and sealing solutions. Its primary products are dispensing pumps closures aerosol valves and elastomer primary packaging components. It also manufactures and sells elastomer primary packaging components which include stoppers for infusion antibiotic lyophilization and diagnostic vials. Its elastomer components also include pre-filled syringe components such as plungers needle shields tip caps and cartridges as well as dropper bulbs and disposable syringe plungers. The Company’s segments include Beauty + Home Pharma and Food + Beverage.